Cargando…

The trends of complementary alternative medicine use among cancer patients

BACKGROUND: The use of complementary and alternative medicine (CAM) is common among cancer patients and it may reflect the individual and societal beliefs on cancer therapy. Our study aimed to evaluate the trends of CAM use among patients with cancer between 2006 and 2018. METHODS: We included 2 Coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jazieh, Abdul Rahman, Abuelgasim, Khadega A., Ardah, Husam I., Alkaiyat, Mohammad, Da’ar, Omar B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188662/
https://www.ncbi.nlm.nih.gov/pubmed/34103037
http://dx.doi.org/10.1186/s12906-021-03338-7
_version_ 1783705369289162752
author Jazieh, Abdul Rahman
Abuelgasim, Khadega A.
Ardah, Husam I.
Alkaiyat, Mohammad
Da’ar, Omar B.
author_facet Jazieh, Abdul Rahman
Abuelgasim, Khadega A.
Ardah, Husam I.
Alkaiyat, Mohammad
Da’ar, Omar B.
author_sort Jazieh, Abdul Rahman
collection PubMed
description BACKGROUND: The use of complementary and alternative medicine (CAM) is common among cancer patients and it may reflect the individual and societal beliefs on cancer therapy. Our study aimed to evaluate the trends of CAM use among patients with cancer between 2006 and 2018. METHODS: We included 2 Cohorts of patients with cancer who were recruited for Cohort 1 between 2006 and 2008 and for Cohort 2 between 2016 and 2018. The study is a cross-sectional study obtaining demographic and clinical information and inquiring about the types of CAM used, the reasons to use them and the perceived benefits. We compared the changes in the patterns of CAM use and other variables between the two cohorts. RESULTS: A total of 1416 patients were included in the study, with 464 patients in Cohort 1 and 952 patients in Cohort 2. Patients in Cohort 2 used less CAM (78.9%) than Cohort 1 (96.8%). Cohort 1 was more likely to use CAM to treat cancer compared to Cohort 2 (84.4% vs. 73%, respectively, p < 0.0001,); while Cohort 2 used CAM for symptom management such as pain control and improving appetite among others. Disclosure of CAM use did not change significantly over time and remains low (31.6% in Cohort 1 and 35.7% for Cohort 2). However, physicians were more likely to express an opposing opinion against CAM use in Cohort 2 compared to Cohort 1 (48.7% vs. 19.1%, p < 0.001, respectively). CONCLUSION: There is a significant change in CAM use among cancer patients over the decade, which reflects major societal and cultural changes in this population. Further studies and interventions are needed to improve the disclosure to physicians and to improve other aspects of care to these patients.
format Online
Article
Text
id pubmed-8188662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81886622021-06-10 The trends of complementary alternative medicine use among cancer patients Jazieh, Abdul Rahman Abuelgasim, Khadega A. Ardah, Husam I. Alkaiyat, Mohammad Da’ar, Omar B. BMC Complement Med Ther Research Article BACKGROUND: The use of complementary and alternative medicine (CAM) is common among cancer patients and it may reflect the individual and societal beliefs on cancer therapy. Our study aimed to evaluate the trends of CAM use among patients with cancer between 2006 and 2018. METHODS: We included 2 Cohorts of patients with cancer who were recruited for Cohort 1 between 2006 and 2008 and for Cohort 2 between 2016 and 2018. The study is a cross-sectional study obtaining demographic and clinical information and inquiring about the types of CAM used, the reasons to use them and the perceived benefits. We compared the changes in the patterns of CAM use and other variables between the two cohorts. RESULTS: A total of 1416 patients were included in the study, with 464 patients in Cohort 1 and 952 patients in Cohort 2. Patients in Cohort 2 used less CAM (78.9%) than Cohort 1 (96.8%). Cohort 1 was more likely to use CAM to treat cancer compared to Cohort 2 (84.4% vs. 73%, respectively, p < 0.0001,); while Cohort 2 used CAM for symptom management such as pain control and improving appetite among others. Disclosure of CAM use did not change significantly over time and remains low (31.6% in Cohort 1 and 35.7% for Cohort 2). However, physicians were more likely to express an opposing opinion against CAM use in Cohort 2 compared to Cohort 1 (48.7% vs. 19.1%, p < 0.001, respectively). CONCLUSION: There is a significant change in CAM use among cancer patients over the decade, which reflects major societal and cultural changes in this population. Further studies and interventions are needed to improve the disclosure to physicians and to improve other aspects of care to these patients. BioMed Central 2021-06-08 /pmc/articles/PMC8188662/ /pubmed/34103037 http://dx.doi.org/10.1186/s12906-021-03338-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Jazieh, Abdul Rahman
Abuelgasim, Khadega A.
Ardah, Husam I.
Alkaiyat, Mohammad
Da’ar, Omar B.
The trends of complementary alternative medicine use among cancer patients
title The trends of complementary alternative medicine use among cancer patients
title_full The trends of complementary alternative medicine use among cancer patients
title_fullStr The trends of complementary alternative medicine use among cancer patients
title_full_unstemmed The trends of complementary alternative medicine use among cancer patients
title_short The trends of complementary alternative medicine use among cancer patients
title_sort trends of complementary alternative medicine use among cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188662/
https://www.ncbi.nlm.nih.gov/pubmed/34103037
http://dx.doi.org/10.1186/s12906-021-03338-7
work_keys_str_mv AT jaziehabdulrahman thetrendsofcomplementaryalternativemedicineuseamongcancerpatients
AT abuelgasimkhadegaa thetrendsofcomplementaryalternativemedicineuseamongcancerpatients
AT ardahhusami thetrendsofcomplementaryalternativemedicineuseamongcancerpatients
AT alkaiyatmohammad thetrendsofcomplementaryalternativemedicineuseamongcancerpatients
AT daaromarb thetrendsofcomplementaryalternativemedicineuseamongcancerpatients
AT jaziehabdulrahman trendsofcomplementaryalternativemedicineuseamongcancerpatients
AT abuelgasimkhadegaa trendsofcomplementaryalternativemedicineuseamongcancerpatients
AT ardahhusami trendsofcomplementaryalternativemedicineuseamongcancerpatients
AT alkaiyatmohammad trendsofcomplementaryalternativemedicineuseamongcancerpatients
AT daaromarb trendsofcomplementaryalternativemedicineuseamongcancerpatients